Investigation of Blastocystis spp. in patients with inflammatory bowel disease by direct microscopy and molecular

Şentürkoğlu Feride1, Samadzade Rugıyya1, Korkmaz Hüseyin2

  • 1Selçuk University, Faculty of Medicine, Department of Medical Microbiology, Konya, Turkey.

African Health Sciences
|February 5, 2026
PubMed
Abstract

Insights

Blastocystis spp. is more prevalent in Ulcerative Colitis patients than in Crohn's disease or healthy individuals. This suggests a potential link between Blastocystis and Ulcerative Colitis, warranting further investigation into this parasitic infection.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Blastocystis spp. is a common eukaryotic protozoan parasite residing in the human and animal intestinal tract.
  • Understanding the role of Blastocystis in gastrointestinal health is crucial.

Purpose of the Study:

  • To investigate the association between Inflammatory Bowel Diseases (IBD), specifically Crohn's disease and Ulcerative Colitis, and the presence of Blastocystis spp.
  • To compare Blastocystis prevalence in IBD patients versus healthy controls.

Main Methods:

  • Stool samples were collected from patients with Crohn's disease (n=25), Ulcerative Colitis (n=30), and healthy controls (n=30).
  • Samples were analyzed using direct microscopic examination and real-time PCR for Blastocystis spp. detection.

Main Results:

  • Blastocystis spp. was detected in 16.6% of Ulcerative Colitis patients and 4% of Crohn's disease patients by microscopy.
  • Real-time PCR identified Blastocystis spp. in 23.3% of Ulcerative Colitis patients, 4% of Crohn's disease patients, and 3.3% of healthy controls.
  • Prevalence was significantly higher in Ulcerative Colitis patients (23.3%) compared to Crohn's disease (4%) and healthy controls (3.3%).

Conclusions:

  • The higher prevalence of Blastocystis spp. in Ulcerative Colitis patients suggests a potential association.
  • Further research is needed to elucidate the specific relationship and potential role of Blastocystis in the pathogenesis of Ulcerative Colitis.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
541
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
632
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
755
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.8K